Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 96 Pancreatic Neoplasms 83 Carcinoma, Non-Small-Cell Lung 79 Ovarian Neoplasms 52 Fallopian Tube Neoplasms 47 Triple Negative Breast Neoplasms 42 Lung Neoplasms 32 Neoplasm Metastasis 27 Squamous Cell Carcinoma of Head and Neck 23 Neoplasms 19 Breast Neoplasms, Male 18 Endometrial Neoplasms 17 Uterine Cervical Neoplasms 16 Melanoma 16 Brenner Tumor 16 Stomach Neoplasms 15 Carcinoma, Ovarian Epithelial 15 Esophageal Neoplasms 13 Adenocarcinoma of Lung 13 Inflammatory Breast Neoplasms 11 Cholangiocarcinoma 10 Adenocarcinoma, Bronchiolo-Alveolar 9 Urinary Bladder Neoplasms 8 Unspecified Adult Solid Tumor, Protocol Specific 8 Oropharyngeal Neoplasms 8 Carcinoma, Transitional Cell 8 Adenocarcinoma Of Esophagus 8 Mouth Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Colorectal Neoplasms 7

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Cystic Neoplasm × Taxes × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡